Terms: = Lymphoma AND BRIP1, MGC126521, 83990, ENSG00000136492, FANCJ, FLJ90232, Q9BX63, MGC126523, OF AND Treatment
716 results:
1. Clinical diagnosis and management of multiple cerebral ring-enhancing lesions-study of 50 patients at a tertiary healthcare center.
Patel A; More B; Rege I; Ranade D
J Cancer Res Ther; 2024 Jan; 20(1):112-117. PubMed ID: 38554307
[TBL] [Abstract] [Full Text] [Related]
2. Evidence for external beam radiotherapy in mediastinal Hodgkin and non-Hodgkin lymphoma - systematic review.
Kowalska M; Sitarz-Kilian E; Jaros K; Koperny M; Moćko P; Siwiec J; Kawalec P
Ann Agric Environ Med; 2024 Mar; 31(1):47-56. PubMed ID: 38549476
[TBL] [Abstract] [Full Text] [Related]
3. Zishen Qingre Lishi Huayu recipe promotes proliferation and inhibits apoptosis of GCs of PCOS via KLF4-C/EBPβ pathway.
Liu S; Xiao M; Jin J; Zhan X; Li X; Ren Y; Yu X; Liu T; Yi Y; Liang R; Peng J
J Ethnopharmacol; 2024 Jun; 328():118027. PubMed ID: 38537844
[TBL] [Abstract] [Full Text] [Related]
4. Aggressive T-cell lymphomas: 2024: Updates on diagnosis, risk stratification, and management.
Ong SY; Zain JM
Am J Hematol; 2024 Mar; 99(3):439-456. PubMed ID: 38304959
[TBL] [Abstract] [Full Text] [Related]
5. treatment of Richter's Transformation with Novel Therapies.
Bajwa A; Habib A; Kittai AS
Curr Hematol Malig Rep; 2024 Apr; 19(2):45-55. PubMed ID: 38194201
[TBL] [Abstract] [Full Text] [Related]
6. Severe sperm DNA fragmentation may persist for up to 3 years after cytotoxic therapy in patients affected by Hodgkin lymphoma and non-Hodgkin lymphoma.
Farnetani G; Vannucci M; Fino MG; Cioppi F; Rosta V; Palma M; Tamburrino L; Vinci S; Casamonti E; Degl'Innocenti S; Spinelli M; Abrardo C; Marchiani S; Lotti F; Muratori M; Riera-Escamilla A; Krausz C
Hum Reprod; 2024 Mar; 39(3):496-503. PubMed ID: 38177083
[TBL] [Abstract] [Full Text] [Related]
7. Integrative Approaches in the treatment of Patients Affected by lymphoma.
Levy Yurkovski I; Andreazzoli F; Ben-Arye E; Attias S; Tadmor T
Curr Oncol Rep; 2023 Dec; 25(12):1523-1534. PubMed ID: 38060095
[TBL] [Abstract] [Full Text] [Related]
8. Blinatumomab in Practice.
Lantz J; Pham N; Jones C; Reed D; El Chaer F; Keng M
Curr Hematol Malig Rep; 2024 Feb; 19(1):1-8. PubMed ID: 38060085
[TBL] [Abstract] [Full Text] [Related]
9. Second-Line Chimeric Antigen Receptor T-Cell Therapy in Diffuse Large B-Cell lymphoma : A Cost-Effectiveness Analysis.
Kelkar AH; Cliff ERS; Jacobson CA; Abel GA; Dijk SW; Krijkamp EM; Redd R; Zurko JC; Hamadani M; Hunink MGM; Cutler C
Ann Intern Med; 2023 Dec; 176(12):1625-1637. PubMed ID: 38048587
[TBL] [Abstract] [Full Text] [Related]
10. Novel Biomarkers and Molecular Targets in ALL.
De Sa H; Leonard J
Curr Hematol Malig Rep; 2024 Feb; 19(1):18-34. PubMed ID: 38048037
[TBL] [Abstract] [Full Text] [Related]
11. Pediatric acute myeloid leukemia - novel approaches.
Karol SE; Gueguen G
Curr Opin Hematol; 2024 Mar; 31(2):47-52. PubMed ID: 37982279
[TBL] [Abstract] [Full Text] [Related]
12. Practical challenges in lung cancer pathology: bedside care to treatment decisions.
Takano AM; Chow CY; Lim KH
Curr Opin Pulm Med; 2024 Jan; 30(1):48-57. PubMed ID: 37937545
[TBL] [Abstract] [Full Text] [Related]
13. Measurable Residual Disease Monitoring in lymphoma.
Cuzzo B; Lipsky A; Cherng HJ
Curr Hematol Malig Rep; 2023 Dec; 18(6):292-304. PubMed ID: 37930608
[TBL] [Abstract] [Full Text] [Related]
14. Towards development of biobetter: L-asparaginase a case study.
Tripathy RK; Anakha J; Pande AH
Biochim Biophys Acta Gen Subj; 2024 Jan; 1868(1):130499. PubMed ID: 37914146
[TBL] [Abstract] [Full Text] [Related]
15. What Is New in Cutaneous T Cell lymphoma?
Morgenroth S; Roggo A; Pawlik L; Dummer R; Ramelyte E
Curr Oncol Rep; 2023 Nov; 25(11):1397-1408. PubMed ID: 37874473
[TBL] [Abstract] [Full Text] [Related]
16. Evolving Role of CAR T Cell Therapy in First- and Second-Line treatment of Large B Cell lymphoma.
Lionel AC; Westin J
Curr Oncol Rep; 2023 Nov; 25(11):1387-1396. PubMed ID: 37861914
[TBL] [Abstract] [Full Text] [Related]
17. What is new in mediastinal staging?
Schwalk AJ; Niroula A; Schimmel M
Curr Opin Pulm Med; 2024 Jan; 30(1):25-34. PubMed ID: 37851368
[TBL] [Abstract] [Full Text] [Related]
18. Determination and mechanism of Xiao-Ai Jie-Du decoction against diffuse large B-cell lymphoma: In silico and In vitro studies.
Zhan XZ; Wei TH; Yin YQ; Xu JQ; Yu H; Chen XL; Kong XT; Sun SL; Li NG; Ni HW
J Ethnopharmacol; 2024 Jan; 319(Pt 2):117271. PubMed ID: 37838296
[TBL] [Abstract] [Full Text] [Related]
19. Real-world expenditures and survival time after CAR-T treatment for large B-cell lymphoma in Switzerland: a retrospective study using insurance claims data.
Trottmann M; Blozik E; Hilbig M; LoVerdi D; Pedruzzi M; Scherer T; Weiss M; Pletscher M; Meier N
Swiss Med Wkly; 2023 Sep; 153():3441. PubMed ID: 37774383
[TBL] [Abstract] [Full Text] [Related]
20. Central Nervous System Relapse in T and NK cell lymphomas.
Taranto EP; Barta SK; Bhansali RS
Curr Hematol Malig Rep; 2023 Dec; 18(6):243-251. PubMed ID: 37620711
[TBL] [Abstract] [Full Text] [Related]
[Next]
